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GENTAMYCIN REDUCES BACTEREMIA
AND MORTALITY RATES ASSOCIATED
WITH THE TREATMENT OF EXPERIMENTAL PERITONITIS
WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
Harry van Goor, M.D.*, Joost S. de Graaf, m.d.*, Kor Kooi, B.sc. , and 
Robert P. Bleichrodt, m.d., ph.d *
and M-G (p<0.01). Gentamycin did not influence the 
number of abscesses.
BACKGROUND: Recombinant tissue plasminogen ac­
tivator (rtPA), administered in trap eritoneally, reduces 
intra-abdominal abscess formation in rats with fecal CONCLUSIONS: Gentamycin reduces bacteremia and 
peritonitis at the costs of increased mortality and early mortality rates in rats with fecal peritonitis treated
Escherichia coli bacteremia. It was determined whether 
or not mortality and bacteremia could be prevented
with rtPA intrap eritoneally to prevent intra-abdominal
abscess formation. J. Am. Coll. Surg., 1995, 181: 38-42.
by gentamycin in these rats.
STUDY DESIGN: Fecal peritonitis was induced by in- I n t r a -a b d o m i n a l  a b s c e s s e s  are an important cause of 
traperitoneal injection of sterile feces contaminated
with 108 (experiment 1) or 104 (experiment 2) colony
forming units (cfu) E. coli and 104 cfu Bacteroides
morbidity and mortality in patients with gener­
alized peritonitis (1). Formation of intra-abdomi­
nal abscesses is mediated by fibrin clots, which
fi'agilis. Male Wistar rats were randomly assigned to are colonized by bacteria (2). Several experimen-
receive either methyl hydroxy propyl cellulose (MHFC ) 
gel alone (M) or 0.5 mg/mL rtPA dissolved in MHPC 
gel (M-tPA). Three hours after inoculation, one-half 
of the rats in each of these groups received 6 mg/kg 
gentamycin sulfate (G) intramuscularly (group M-G 
and M-tPA-G). At one, three, six, 12, and 24 hours 
after inoculation, blood cultures were taken. At five 
days after inoculation, intra-abdominal abscess for­
mation was assessed and abscesses were cultured (ex­
periment 2).
RESULTS: All rats in groups M and M-tPA in experi­
ment 1 developed bacteremia and died within 24
tal studies have been attempted to prevent the 
formation of intra-abdominal abscesses by inhi­
bition of fibrin formation with heparin or by 
activation of fibrinolysis with plasminogen acti­
vators (3, 4). In a previous experiment, we dem­
onstrated a reduction of intra-abdominal abscesses 
with the use of a viscous gel that contained re­
combinant tissue plasminogen activator (rtPA) in 
rats with generalized peritonitis (5). However, rats 
treated with rtPA had an increased mortality rate, 
and early Escherichia coli (E. coli) bacteremia was 
observed more frequently, probably as a result 
of early degradation of fibrin. In the present
hours. Bacteremia occurred significantly earlier in study, it was determined whether or not mortality 
group M-tPA compared with group M (p<0.05). Gen- and bacteremia could be prevented by the ad- 
tamycin significantly reduced the number of rats with ministration of gentamycin in rats with general- 
bacteremia, the bacterial concentration in the blood, ized peritonitis treated with rtPA in traperi tone ally 
and mortality rates. Although in experiment 2 none 
of the rats developed bacteremia, gentamycin pre­
vented mortality associated with the use of rtPA. The 
number of abscesses in groups M-tPA and M-tPA-G
MATERIALS AND METHODS
was significantly lower than in those in groups M
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Design of the study. Experiment 1.—Male Wistar 
rats, weighing between 255 and 290 g were used. 
Generalized peritonitis was induced by intraperi- 
toneal injection of 2 mL fecal suspension con­
taining 108 colony forming units (cfu)/mL E. 
coli and 104 cfu/mL Bacteroides fragilis (B. fragilis). 
After one hour, a midline laparotomy was per­
formed under general anesthesia (halothane-ni-
38
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Fig. 1. Percentage o f  rats with bacterem ia at three, six, and 12 hours after 
inoculation o f 2 mL sterile feces contam inated with I08 colony form ing units 
(cfu )/m L  Escherichia coli and 104 cfu /m L  Bacteroides fragilis. At six hours, there 
was a significant effect o f gentamycin in both groups receiving gentamycin (methyl 
hydroxy propyl cellulose gel [M] plus gentamycin [G] and M plus recom binant 
tissue plasm inogen activator [tPA] plus G). T he differences were more pronounced  
at 12 hours. At six hours, significandy (p<0.05) m ore rats in group M-tPA than 
in the group receiving M had  bacteremia.
trous oxide-oxygen mixture). The abdomen was 
debrided (including partial omentectomy) and 
rinsed with normal saline solution. Before closure 
of the abdomen, the rats received either 2.5 mL 
methyl hydroxy propyl cellulose (MHPC) (Clinical 
Pharmacy, Groningen, The Netherlands) gel 
(n=14) or 2.5 mL MHPC gel containing 0.5 m g/m L
human rtPA (Boehringer Ingelheim, Alkmaar, 
The Netherlands) (n=20) intraperitoneally. Methyl 
hydroxy propyl cellulose gel was used as a vehicle. 
After operation, 5 mL of normal saline solution 
were administered subcutaneously for resuscita­
tion. At three hours after induction of peritonitis, 
one-half of the rats in each group received gen­
tamycin sulfate, 6 mg/kg body weight, intramus­
cularly (IM) in a single dose. Thus, four experi­
mental groups were formed: MHPC gel alone (M), 
MHPC gel plus rtPA (M-tPA), MHPC gel plus 
gentamycin (M-G), and MHPC gel plus rtPA plus 
gentamycin (M-tPA-G). At one, three, six, 12, 
and 24 hours after inoculation, blood samples 
(0.45 mL) were taken by cardiac puncture while 
rats were under general anesthesia to assess bac­
teremia. Lost blood volume was compensated by 
subcutaneous administration of 2 mL of normal
saline solution. Five days after inoculation, the 
surviving rats were sacrificed by intracardial pen­
tobarbital (Nembutal®, A bbott Laboratories, 
North Chicago, IL) injection and inspected for 
intra-abdominal abscess formation.
Experiment 2.—In a similar experiment, pub­
lished previously (5), we inoculated 104 instead 
of 108 cfu/mL E. coli It was found that mortality 
rates in rats treated with rtPA were significantly 
higher but bacteremia was not observed. In the 
present study, this experiment was repeated, in­
cluding a group of rats receiving gentamycin IM.
The same model of intra-abdominal infection 
and treatment was used as already described. Fe­
cal suspension contained 104 cfu/mL E . coli and 
B. fragilis. At laparotomy, the rats received either 
2.5 mL of MHPC gel (n=16) or 2.5 mL of MHPC 
gel containing 0.5 mL/mg rtPA (n=24). Half of 
the rats in each group received gentamycin sulfate 
(6 m g/kg body weight IM, three hours after in­
oculation) . Thus, analogous experimental groups 
to those in experiment 1 were obtained. Blood 
cultures were taken at three, six, 12, and 24 
hours after inoculation. Five days after inocula­
tion, the abdomens of surviving rats were re-
40 Journal of the American College of Surgeons * July 1995 * Volume 181
p<0.05 p<0.05
100% -
mortality
80% -
60% -
40%
20%  -
of incubation at 37 degrees C, bacteria were 
counted and identified. Bacterial concentration 
was expressed in 10log cfu/mL whole blood.
Statistics. Statistical analysis was performed using 
chi-square test, Yates and Cochran or Kruskall 
Wallis rank analysis, when appropiate. When the 
p value was less than 0.05, a difference between 
groups was considered significant.
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Fig. 2. Mortality rate in rats after inoculation o f sterile 
feces contaminated with 108 Escherichia coli and 104 Bac- 
teroides fragilis. Mortality is significantly (p<0.05) reduced 
by gentamycin, M} Methyl hydroxy propyl cellulose gel; 
tPA, tissue plasminogen activator; and G, gentamycin sulfate.
opened under sterile conditions and abscesses 
were counted. If present, abscesses on different 
spots were excised for culture. During the ex­
periments, the rats had free access to water and 
standard rat chow (MH-B 1010, Hope Farms, Wo- 
erden, The Netherlands).
Bacterial fecal suspension. Escherichia coli strain 
American Type Culture Collection (ATCC)
25922 and B, fragilis from a clinical isolate were 
used. Bacteria were cultured according to stand­
ard methods. The mean inhibitory concentration 
of gentamycin for this £. coli strain was 0.5 mg/L 
as measured by the E-test (AB Biodisk, Solna,
Sweden).
Fresh feces of Wistar rats were prepared as 
described previously (5). Prior to intraperitoneal 
injection, the sterile fecal suspension was vigor­
ously mixed with the bacterial suspensions.
Cultures of abscesses. The excised abscesses were 
cultured semiquantitatively using standard aero­
bic and anaerobic bacteriologic techniques.
Blood cultures. Blood (0.45 mL) was collected 
in sterile tubes containing 0.05 mL buffered cit­
rate. Serial dilutions in brain-heart infusion broth
were made and plated onto both aerobic (Mac- were not found in any rat during this experiment.
Conkey, blood agar; Oxoid, Hampshire, United Surprisingly, gentamycin prevented mortality:
Kingdom) and anaerobic (Bacteroides Bile Escu- 0/12 in group M-tPA-G compared with 5/12 in
line agar, Brucella Blood agar; Becton-Dickinson, group M-tPA; p<0.05. None of the eight rats in
Baltimore, USA) plates. After 24 and 48 hours group M-G died.
RESULTS
Experiment L  At one hour after inoculation, none 
of the rats had bacteremia. At 12 hours after 
inoculation, all rats in group M and M-tPA had 
bacteremia, and all died within 24 hours. Bac­
teremia occurred earlier in rats in group M-tPA 
in comparison with those in group M, as reflected 
by a significantly (p<0.05) higher number of rats 
with bacteremia at six hours after inoculation 
(Fig. 1). Gentamycin significantly reduced the 
number of rats with bacteremia: in the M-tPA-G 
group at six and 12 hours and in the M-G group 
at 12 hours after inoculation* Also, the mortality 
rate was significantly (p<0.05) reduced by gen­
tamycin in these groups of rats (Fig. 2).
At 12 hours after inoculation, blood cultures 
revealed a median bacterial concentration of 10J, 
ranging from 102 to IQ7, in rats in group M 
and M-tPA. The bacterial concentration was sig­
nificantly (p<0.05) reduced in rats treated with 
gentamycin to a median concentration of zero 
(range, zero to 107). However, the bacterial con­
centration in the one rat in group M-G and the 
three rats in group M-tPA-G that had bactere­
mia did not differ significantly from those
in group M and M-tPA: 104 (range, 102 to 105) 
compared with 105 (range, 102 to 107). Only E, 
coli ATCC 25922 was isolated from the blood. 
At 24 hours after inoculation, all blood cultures 
available from surviving rats revealed no growth, 
Three of the six surviving rats in group M-tPA-G 
were free of intra-abdominal abscesses at day 5, 
whereas all five surviving rats in group M-G had 
multiple intra-abdominal abscesses.
Experiment 2. When inoculated with 104 E . coli, 
five out of 12 rats (42 percent) in group M-tPA 
died compared to zero out of eight rats (zero 
percent) in group M. Rats died between 12 and 
24 hours after inoculation and none of them 
had abscesses at autopsy. Positive blood cultures
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TABLE I.—BACTERIOLOGY OF INTRA-ABDOMINAL ABSCESSES IN SURVIVING RATS WITH POSITIVE CULTURES
Rats with E. coli ATCC 25922__ __Rats with other species*
Group Rats with positive cultures, n n Percent n Percent
M ............................................................................................8 7 88 4 50
M-G.........................................................................................6 4 67 6 100
M-tPA...................................................................................... 6 6 100 1 17
M-tPA-G................................................................................ 9 7 78 6 67
*Other species are Enterococci, Staphylococci, Proteus, and Candida, which were not sensitive to gentamycin.
n, Number of patients; M, methyl hydroxy propyl cellulose; tPA, tissue plasminogen activator; G, gentamycin sulfate; ATCC, American Type Culture 
Collection; and E. coli, Escherichia coli.
Five days after inoculation, intra-abdominal ab­
scesses were found in all rats in group M and 
M-G, in six of seven surviving rats in group M-tPA, 
and in 11 of 12 rats in group M-tPA-G. In four 
rats (two in group M-G, two in group M-tPA-G), 
no bacteria were isolated from the excised ab­
scesses. In rats with positive cultures of intra-ab­
dominal abscesses and treated with rtPA, the me­
dian number of abscesses was significantly lower 
(p<0.01) than in those not treated with rtPA: 
three (range, 1 to 4) in group M-tPA and four 
(range, 1 to 8) in group M-tPA-G compared with 
11 (range, 8 to 15) in group M and ten (range, 
7 to 13) in group M-G. Gentamycin did not in­
fluence the number of abscesses, Escherichia coli 
ATCC 25922 was cultured from abscesses in most 
cases (Table I). In contrast, B. fragilis was not 
found. Other species seemed to be more fre­
quently isolated from abscesses in rats treated 
with gentamycin compared with those not treated 
with gentamycin.
DISCUSSION
The present study demonstrates that antibiotic 
treatment markedly reduces early bacteremia and 
reduces the mortality rate in rats with generalized 
peritonitis that are treated with rtPA to prevent 
the formation of residual abscesses. Fibrin entraps 
bacteria, thus preventing early bacteremia and 
mortality in generalized peritonitis (2, 6). How­
ever, these colonized fibrin clots are the nidus 
for intra-abdominal abscesses. It is expected that 
intra-abdominal application of rtPA to prevent 
these abscesses will cause early bacteremia. In 
concordance with previous findings, early bac­
teremia occurred in association with the use of
rtPA (4, 5).
A single dose of 6 m g/kg gentamycin sulfate, 
administered intramuscularly three hours after 
onset of peritonitis, reduced bacteremia and mor­
tality rates in experiment 1, and the mortality 
rate in experiment 2. Recombinant tissue plas­
minogen activator appeared to be the main factor 
reducing abscess formation in contrast to gen­
tamycin. Several authors have reported the in­
ability of antibiotics to reduce abscess formation 
(6-8). Hau and associates have demonstrated, 
using a fibrin clot model, that gentamycin, like 
several other antibiotics, does not influence ab­
scess formation mainly because inhibitory levels 
within the fibrin clot are not reached (7). How­
ever, in the same model, a reduction of colony 
count per abscess by gentamycin sulfate has been 
reported (8), We did not quantitate bacteria in 
abscesses. Qualitatively, the use of gentamycin 
seemed to have altered the bacterial flora of the 
abscesses. The absence of B. fragilis in the ab­
scesses was remarkable. This might be due to 
the peritonitis model used, as was pointed out 
previously (5),
From this and previous studies (4, 5, 9), it 
emerges that intra-abdominal administration of 
rtPA may be a valuable adjunct to the standard 
treatment of patients with generalized peritonitis 
in order to prevent intra-abdominal abscess for­
mation. Antibiotics directed against the causal 
bacteria are an essential part of this treatm ent 
With the use of appropiate antibiotics, the risk 
of bacteremia associated with the use of rtPA 
in the clinical situation is expected to be minor. 
Bleeding, another potential risk of the use of 
rtPA clinically, has so far not been observed in 
experiments wherein rtPA has been administered 
into the abdominal cavity (5, 10).
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